Learning Objectives:

1.  Understand the physiology of FGF23.

2.  Describe the pathophysiology of TIO.

3.  Understand how new anti FGF23 therapy impacts the treatment of TIO.

Session date: 
11/04/2024 - 5:00pm to 6:00pm CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Suzanne M. Jan de Beur, M.D.